Lamotrigine Extended Release
Product Images NDC 52817-243

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine Extended Release (NDC 52817-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is The 100mg Label (Lamotrigine Extended Release Tablet 100mg)

Lamotrigine Extended Release 100 mg tablets packaging label from TruPharma, LLC. The label states it is Rx only and contains 30 film-coated tablets. It includes instructions for storage at 20° to 25°C, a caution to verify the product dispensed, and a reminder to dispense the accompanying Medication Guide to each patient. The label also shows the NDC 52817-242-30 and a small tablet image with imprint 'H 012'.*

FDA Label Image

This Is The 200mg Label (Lamotrigine Extended Release Tablet 200mg)

Label for Lamotrigine Extended-Release Tablets 200 mg, manufactured by TruPharma, LLC. The label includes dosage information as once a day and states the quantity as 30 tablets. It features storage instructions, a barcode, and cautions to verify the product dispensed and to provide the accompanying Medication Guide to each patient. The label is marked Rx only.*

FDA Label Image

This Is The 25mg Label (Lamotrigine Extended Release Tablet 25mg)

Label of Lamotrigine Extended-Release Tablets, 25 mg strength, by TruPharma, LLC. The label indicates the tablets are for once daily use and contain extended-release film-coated lamotrigine. The package contains 30 tablets and includes cautions to verify product dispensed and to dispense the accompanying medication guide. The label shows storage instructions and a barcode.*

FDA Label Image

This Is The 50mg Label (Lamotrigine Extended Release Tablet 50mg)

Lamotrigine Extended Release 50 mg tablets bottle label by TruPharma, LLC. The label indicates 30 extended-release film-coated tablets per container, with storage instructions and caution to verify product dispensed. The product is prescription only and each tablet contains 50 mg lamotrigine USP.*

FDA Label Image

This Is Figure 1 (Lamotrigine Extended Release Tablet Fig01)

This is a responder rate curve comparing Lamotrigine Extended Release (N=70) to placebo (N=73). The vertical axis shows responder rate from worsening to improvement, while the horizontal axis represents percent of patients, illustrating the difference in response between the two groups.*

FDA Label Image

Fig1 (Lamotrigine Extended Release Tablet Fig02)

A Kaplan-Meier-type survival curve chart comparing responder rates between Lamotrigine Extended Release and Placebo. The y-axis represents responder rate from -100% (worsening) to 100% (improvement). The x-axis shows percent of patients from 100 to 0. Two lines depict treatment groups: solid for Lamotrigine ER and dashed for Placebo.*

FDA Label Image

Chemical Structure (Lamotrigine Extended Release Tablet Str)

Chemical structure of lamotrigine, the active ingredient in Lamotrigine Extended Release, as submitted by TruPharma, LLC. The diagram shows the arrangement of chlorine atoms and nitrogen-containing rings characteristic of lamotrigine's molecular structure.*

FDA Label Image

Tablet Images (Lamotrigine Extended Release Tablets)

A text panel listing Lamotrigine Extended-Release Tablets in four strengths and colors: 25 mg white to off-white round tablets imprinted with H008, 50 mg peach round tablets imprinted with H009, 100 mg yellow round tablets imprinted with H012, and 200 mg blue round tablets imprinted with H011.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.